Literature DB >> 19548844

Chromosome 9p21 polymorphism is associated with myocardial infarction but not with clinical outcome in Han Chinese.

Wen Hui Peng1, Lin Lu, Qi Zhang, Rui Yan Zhang, Ling Jie Wang, Xiao Xiang Yan, Qiu Jing Chen, Wei Feng Shen.   

Abstract

BACKGROUND: rs1333049 polymorphism on chromosome 9p21 has been shown to affect susceptibility to coronary artery disease (CAD) in Caucasians. This study examined the association of rs1333049 with myocardial infarction (MI), angiographic severity of CAD and clinical outcome after a first acute MI in Han Chinese.
METHODS: rs1333049 polymorphism was genotyped in 520 patients with a first acute MI and in 560 controls. The number of angiographically documented diseased coronary arteries (luminal diameter stenosis > or = 50%), echocardiographic left ventricular ejection fraction (LVEF), and major adverse cardiac events (MACE) during follow-up (mean, 29+/-15 months) were recorded.
RESULTS: Patients with MI had higher frequencies of the CC genotype (30.0% vs. 20.7%) or C allele (55.5% vs. 46.2%) compared with controls (all p<0.01). rs1333049 polymorphism was strongly associated with MI [odds ratio (OR) 1.48, 95% confidence interval (CI) 1.22-1.79] after adjusting for traditional risk factors. Although longer hospitalization stay was observed in patients with the rs1333049-C allele, this polymorphism was not related to angiographic severity of CAD, LVEF, and occurrence of MACE after MI.
CONCLUSIONS: This study demonstrates an association of rs1333049 polymorphism locus on chromosome 9p21 with risk for MI, but not with post-MI prognosis in Han Chinese.

Entities:  

Mesh:

Year:  2009        PMID: 19548844     DOI: 10.1515/CCLM.2009.215

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  16 in total

1.  The rs1333049 polymorphism on locus 9p21.3 and extreme longevity in Spanish and Japanese cohorts.

Authors:  Tomàs Pinós; Noriyuki Fuku; Yolanda Cámara; Yasumichi Arai; Yukiko Abe; Gabriel Rodríguez-Romo; Nuria Garatachea; Alejandro Santos-Lozano; Elisabet Miro-Casas; Marisol Ruiz-Meana; Imanol Otaegui; Haruka Murakami; Motohiko Miyachi; David Garcia-Dorado; Kunihiko Hinohara; Antoni L Andreu; Akinori Kimura; Nobuyoshi Hirose; Alejandro Lucia
Journal:  Age (Dordr)       Date:  2013-10-28

2.  Chromosome 9p21.3 polymorphism in a Chinese Han population is associated with angiographic coronary plaque progression in non-diabetic but not in type 2 diabetic patients.

Authors:  Wei Wang; Wenhui Peng; Xianling Zhang; Lin Lu; Ruiyan Zhang; Qi Zhang; Lingjie Wang; Qiujing Chen; Weifeng Shen
Journal:  Cardiovasc Diabetol       Date:  2010-08-06       Impact factor: 9.951

3.  Association between 9p21.3 genomic markers and coronary artery disease in East Asians: a meta-analysis involving 9,813 cases and 10,710 controls.

Authors:  Jin Guo; Wei Li; Zhenqiang Wu; Xiaoru Cheng; Yang Wang; Tao Chen
Journal:  Mol Biol Rep       Date:  2012-10-20       Impact factor: 2.316

4.  Genetic Variant rs10757278 on Chromosome 9p21 Contributes to Myocardial Infarction Susceptibility.

Authors:  Guangyuan Chen; Xiuhua Fu; Guangyu Wang; Guiyou Liu; Xiuping Bai
Journal:  Int J Mol Sci       Date:  2015-05-21       Impact factor: 5.923

Review 5.  Genetic variants at chromosome 9p21 and risk of first versus subsequent coronary heart disease events: a systematic review and meta-analysis.

Authors:  Riyaz S Patel; Folkert W Asselbergs; Arshed A Quyyumi; Tom M Palmer; Chris I Finan; Vinicius Tragante; John Deanfield; Harry Hemingway; Aroon D Hingorani; Michael V Holmes
Journal:  J Am Coll Cardiol       Date:  2014-03-07       Impact factor: 24.094

6.  New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease.

Authors:  Wei Yuan; Wei Zhang; Wei Zhang; Zhong-Bao Ruan; Li Zhu; Yu Liu; Yuan-Yuan Mi; Li-Feng Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

7.  Current genomics in cardiovascular medicine.

Authors:  Vinit Sawhney; Scott Brouilette; Dominic Abrams; Richard Schilling; Benjamin O'Brien
Journal:  Curr Genomics       Date:  2012-09       Impact factor: 2.236

8.  Methylation of p15INK4b and expression of ANRIL on chromosome 9p21 are associated with coronary artery disease.

Authors:  Jianhui Zhuang; Wenhui Peng; Hailing Li; Wei Wang; Yidong Wei; Weiming Li; Yawei Xu
Journal:  PLoS One       Date:  2012-10-16       Impact factor: 3.240

9.  Polymorphism of 9p21.3 locus is associated with 5-year survival in high-risk patients with myocardial infarction.

Authors:  Anna Szpakowicz; Witold Pepinski; Ewa Waszkiewicz; Dominika Maciorkowska; Małgorzata Skawronska; Anna Niemcunowicz-Janica; Robert Milewski; Sławomir Dobrzycki; Włodzimierz Jerzy Musial; Karol Adam Kaminski
Journal:  PLoS One       Date:  2013-09-12       Impact factor: 3.240

10.  The chromosome 9p21 variant not predicting long-term cardiovascular mortality in Chinese with established coronary artery disease: an eleven-year follow-up study.

Authors:  I-Te Lee; Mark O Goodarzi; Wen-Jane Lee; Jerome I Rotter; Yii-der Ida Chen; Kae-Woei Liang; Wen-Lieng Lee; Wayne H-H Sheu
Journal:  Biomed Res Int       Date:  2014-04-02       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.